Drug · DIN 02435292
ATORVASTATIN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 10, 2025.
- Drug Identification Number (DIN)
- 02435292
- Company (DIN owner)
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Atorvastatin C10AA05
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ATORVASTATIN (ATORVASTATIN CALCIUM) | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 19, 2014: NOC 16463Abbreviated New Drug Submission (ANDS) · Additional product name
Other DINs named ATORVASTATIN
- DIN 02348705 · Marketed
- DIN 02348713 · Marketed
- DIN 02348721 · Marketed
- DIN 02348748 · Marketed
- DIN 02545462 · Marketed
- DIN 02545470 · Marketed
- DIN 02545489 · Marketed
- DIN 02545497 · Marketed
- DIN 02348624 · Cancelled Post Market
- DIN 02348632 · Cancelled Post Market
- DIN 02348640 · Cancelled Post Market
- DIN 02348659 · Cancelled Post Market
- DIN 02387891 · Cancelled Post Market
- DIN 02387905 · Cancelled Post Market
- DIN 02387913 · Cancelled Post Market
- DIN 02387921 · Cancelled Post Market
- DIN 02396424 · Cancelled Post Market
- DIN 02396432 · Cancelled Post Market
- DIN 02396440 · Cancelled Post Market
- DIN 02396459 · Cancelled Post Market